This edition of the ever-popular BioTuesday event format will spotlight ‘The Latest R&D in Cell & Gene Therapy’. 

During this BioTuesday you’ll hear from cell therapy R&D leaders blazing trails in clinical trials, expert C&G therapy manufacturing and support organisations, plus innovators pushing ever further the boundaries of C&G therapy with next-gen technologies.

Programme:

18.00 – 18.30 Guest arrivals and networking

From 18.30, Welcome: Phillip Simister, Head of Science & Entrepreneur Advocate, OBN​

Keynote Presentation: Jo Brewer, CSO​ at Adaptimmune​

Followed by 10-minute presentations from:

Dimor Elbers​, Associate Director Licensing at Lonza​

Kevin Takuya Vela​, Collaborations Manager at the Cell & Gene Therapy Catapult​, ‘Implementing automation and digitisation of ATMP manufacture to improve global patient access’

Lara Campana​, VP Research Operations and Co-Founder of Resolution Therapeutics​

Felix Dobbs​, Co-Founder & CEO of Broken String Biosciences​

Anastasia Maslova​, Senior Research Scientist at Oxford Gene Technologies​

20.00 – 20.30  Audience & Presenter Q&A

20.30 – 21.30 Networking